Member Info for BIGBangs

For ‘Innova to throw us a bone’ they would first need to get home use, none professional, MHRA authorisation. They are currently supplying the NHS under emergency powers that end on 22nd June.

I always try to give you the benefit of the doubt Computer in that you are genuinely invested but not unreasonably, frustrated that production/orders are taking longer than anyone expected. Therefore, I would say that CK issued the RNS aware that AVCT would be making an announcement confirming approval for professional use and in an attempt to calm investors here that everything is ready, discussions are ongoing with likely providers and that ODX themselves acknowledge that getting HMG to commit to a test which I feel will come with home use approval, is taking longer than expected. If no RNS had been issued today I believe the SP would have fallen more. Hold.

‘The ability to supply tests that are produced within the UK remains a key priority for the DHSC and to that end the DHSC have facilitated initial commercial discussions between Omega and potential partner companies with lateral flow antigen tests to potentially provide UK manufacturing services.’

We know how careful ODX are with the wording of their RNS so I was grateful that we received this today. We have confirmation again that HMG still intend for the sovereign test to be produced within the UK by ODX and two others. The RNS goes on to state that DHSC has facilitated commercial discussions with potential partner companies (note the plural), I am as frustrated as anyone with the delay but the RNS is positive, hold hard.

I think I agree with you Mars, Mologic most likely - just want them to get on with it. If the news is confirmed then perhaps finally we will see some substantial buys by the institution’s taking their stake above the notifiable amount. They normally hear things first giving them the opportunity to take advantage so big buys will also mean news likely. Here’s hoping.

I agree none of us know which test will be given the green light and it could be either, both or worst case neither. What I am hoping to establish is the speed at which ODX can begin manufacture - I link ODX to AVCT from the job advert or it may have been a LinkedIn update by a member of ODX staff who’s job it was to work on AVCT project.

Swampy = sample

You make a good point racquet - knowing little about the specifics for AVCT I am willing to take your comments without debate. Presumably as Mologic have been involved with the development of the AVCT test they will have encouraged the same ‘hardware’ and the difference being the ‘chemical’ that we add our swampy too? This would mean that if it were the AVCT test that was the sole beneficiary of the sovereign test award ( I have stated many times that I believe there is room for more than one) then ODX would already have the TT in place and be able to begin manufacture without delay simply adding the AVCT package instead of the Mologic one? Any views?

Lots of speculation in today’s press that freedom day could be delayed for an initial two weeks to gather more data about the effects of the Indian variant. The point to note is that they have stated that freedom day still likely on 21st unless we see hospital admissions increase, not just cases, remember we lock down to protect the NHS from being overwhelmed. My own view is that freedom day will continue as planned as politically it is still difficult to move, the vaccination program continues at pace, most vulnerable people have had two jabs and many more have some protection from at least one jab, therefore hospitalisation will not increase but remain flat. Personally I do not think we should be vaccinating children as they have little risk from contracting the disease which gives us more scope to double vaccinate all adults and begin to distribute more vaccine to other countries where health care workers and the vulnerable have no protection. I believe at some point approval and orders for our production of the sovereign test which I still believe will be Modena, (although room for more than one) has become linked to freedom day.

I think it is a fake a mash up of the Jan 21 bidstats report £571 million 73 suppliers ODX £374m. I hope I am wrong. Our time will come.

Are we sure this is not a fake? Very happy if it is confirmed 3 years at £187m per annum would be an excellent end to the day. Who vouches for this?

For some reason I struggled with this report a little but on my reading the data is from 5th May. We do not actually know the number of Innova tests stockpiled or still to be used but with about 43 million people in the uk whatever the number is it will if necessary with the right prompting or changing circumstances be used up quickly - we could also play our part in the larger world by perhaps directing some of the Innova stock to developing countries and perhaps allocate the cost against our 0.5 GDP aid budget. Whatever the take up you know that I believe our production will be fully sold, I would just like us to be given the green light to get on with it.

From today’s Mail.

Gove came into contact with someone testing positive and was notified by his app. Instead of having to isolate he will be tested every day by a LFT - this must be the way forward to open up and is great news for ODX.

The daily test pilot scheme is open to anyone identified by Test and Trace as having come into contact with someone who has tested positive for Covid.
It is looking to recruit around 40,000 people to see if it is a viable alternative to disruptive home quarantine.
Instead of staying holed-up at home for 10 days, participants are sent a week's worth of lateral flow tests and, assuming they pass every day, will be able to go about their lives more or less as before.
They will have to test themselves every morning for seven days.
People who test negative and develop no symptoms will be exempt from the legal duty to self-isolate that day and can leave their home to carry out essential activities like work.
They will need to take another test the next morning to see if they need to self-isolate that day or continue to be exempt. Individuals will still have to adhere to current restrictions, including following the rules on hands, face and space, and only those formally enrolled in the research study will be exempt from usual legal duties.
To be eligible people have to be free from Covid-19 symptoms, live in England, be aged 18 or over and be outside of full-time education and not subject to quarantine rules for arriving in England from abroad.
However, people will not be able to take part if they have been informed that they have been in contact with someone who’s tested positive with a variant of concern or variant under investigation.
At the launch of the scheme PHE's Professor Isabel Oliver, the study leader, said: 'We know that isolating when you have been in contact with someone who has tested positive for COVID-19 is challenging but it remains vitally important to stop the spread of infection. This study will help to determine whether we can deploy daily testing for contacts to potentially reduce the need for self-isolation, while still ensuring that chains of transmission are stopped.'‘

No criticism intended but I find it amusing that yesterday’s board was full of comments that there would not be enough demand to justify orders from ODX and today the theme seems to be that there will be too big a requirement for ODX to play a part. I will go with the three bears solution and believe that whatever the level of demand it will be just enough for ODX as one of the chosen 3 sovereign test providers to play their full part. ATB

Yet the SP continues to drift. I certainly may have rose tinted spectacles but I fail to understand why people continue to see. If you are reading this and have sold please enlighten me, where else have you invested your money (presumably selling here at a loss) that you believe offers a better opportunity than here? Please this is a genuine enquiry and not meant as a criticism of your own personal investment decisions.

Sorry Penance, I am struggling to understand the criticism, please explain. Thanks

I agree that the antibody test roll out has been disappointing - some of that must be put down to the Goodlaw project taking ABDX to court but the demand many of us, certainly me included, had anticipated has just not been there. I keep reading that the need for antibody testing is still just around the corner but it never quite seems to materialise. I can only hope that negotiations are ongoing about suppling Visitect worldwide but yes we need news perhaps we need the validation of a sovereign test confirmation to get things moving on all fronts - that looks increasingly likely to me. I would anticipate all of our activity and efforts are devoted to COVID testing and that our other projects are languishing perhaps the developments we have made over this period will ultimately benefit our other products once the world has time to think about such things again.

We have seen what can happen when the company comments on Twitter about anything other that product and development and until there is news they have nothing to release via RNS - nothing to be done but wait and as long as you ultimately retain enough faith in the product the company and in assurances/contracts from HMG that is all you can do.

Great point Regulator and one which many of us have overlooked.

Although I am far from happy with the delay, as experienced entrepreneurs what do we expect Colin to actually do at this point. He has a signed order from the government, he has been given machinery to produce anticipated orders, HMG have provided funding to cover all of the costs plus a 18% profit margin and we have been assured we are one of three manufacturers that will be asked to produce the sovereign test. He could turn round and say despite all this my shareholders are unhappy with the speed that things are progressing which is holding back our share price but personally I don’t think the government would take much notice. I would hope that Colin is constantly reminding HMG that we are ready and waiting and that we have diverted all our time and resources to preparing for the government confirmation that has probably meant we have missed other opportunists but I expect he is doing just that.

Well putting me on the spot Computer I would say, firstly they have said they anticipate a need for 2 million tests per day, secondly once everything is open it would be politically unwise not to provide tests for the public sector, secondary school children who are unlikely to be vaccinated, thirdly key and care home workers. HMG can easily change the date from 30th June. Would I be a heretic to also suggest that companies could be expected to pay for their own employee tests at some point? And of course we know not everyone is vaccinated and those that are are not 100% protected.

But that is testing while we are in a semi lock down and not reflective of the increases expected by HMG once we fully open up and get back to work.